Literature DB >> 18796443

Oxidative stress in prehypertension: rationale for antioxidant clinical trials.

Selvaraj Nambiar1, Sathiyapriya Viswanathan, Bobby Zachariah, Nandeesha Hanumanthappa, Sridhar Gopalakrishna Magadi.   

Abstract

Prehypertension has been recently described as an independent category of blood pressure. Mounting evidence suggests that blood pressure in the prehypertensive range is associated with an increased risk of developing hypertension and cardiovascular disease. Several reports have assigned a critical role for oxidative stress in these disease processes. This review focuses on the clinical and experimental studies done in prehypertension and hypertension within the context of oxidative stress. This article also provides insights into why diverse therapeutic interventions, which have in common the ability to reduce oxidative stress, can impede or delay the onset of hypertension in prehypertension subjects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796443     DOI: 10.1177/0003319708319781

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

Review 1.  Beneficial and harmful effects of exercise in hypertensive patients: the role of oxidative stress.

Authors:  Milica Dekleva; Jelena Suzic Lazic; Aleksandra Arandjelovic; Sanja Mazic
Journal:  Hypertens Res       Date:  2016-07-21       Impact factor: 3.872

Review 2.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

Review 3.  Oxidative stress and hypertension: current concepts.

Authors:  Ana M Briones; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

4.  Central hemodynamics in prehypertension: effect of the β-adrenergic antagonist nebivolol.

Authors:  Jason T Davis; Dalal N Pasha; Srikrishna Khandrika; Maple M Fung; Milos Milic; Daniel T O'Connor
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-10-26       Impact factor: 3.738

5.  Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment.

Authors:  Soundravally Rajendiran; Bobby Zachariah; Abdoul Hamide
Journal:  Saudi J Gastroenterol       Date:  2012 Jul-Aug       Impact factor: 2.485

6.  The association of the vanin-1 N131S variant with blood pressure is mediated by endoplasmic reticulum-associated degradation and loss of function.

Authors:  Ya-Juan Wang; Bamidele O Tayo; Anupam Bandyopadhyay; Heming Wang; Tao Feng; Nora Franceschini; Hua Tang; Jianmin Gao; Yun Ju Sung; Robert C Elston; Scott M Williams; Richard S Cooper; Ting-Wei Mu; Xiaofeng Zhu
Journal:  PLoS Genet       Date:  2014-09-18       Impact factor: 5.917

7.  A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.

Authors:  H Bentsen; K Osnes; H Refsum; D K Solberg; T Bøhmer
Journal:  Transl Psychiatry       Date:  2013-12-17       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.